| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| P/E Ratio | - | - | 57.518 | 16.551 |
| Return on Equity | 8.182 | -20.476 | 6.942 | 2.935 |
| Net Profit Margin | -31.454 | 40.797 | -35.887 | - |
| Debt to Asset Ratio | 166.576 | 164.815 | 223.993 | 224.9 |
| Cash Ratio | 51.99 | 55.8 | 25.749 | 28.803 |
| Quick Ratio | 118.276 | 118.828 | 70.168 | 76.349 |
| Current Ratio | 152.971 | 153.775 | 100.399 | 114.658 |
Esperion Therapeutics, Inc. (ESPR)
Esperion Therapeutics, Inc. (ESPR)